---
category: news
title: "Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer"
excerpt: "Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's investigational new drug"
publishedDateTime: 2021-12-24T13:35:00Z
originalUrl: "https://www.lelezard.com/en/news-20171157.html"
webUrl: "https://www.lelezard.com/en/news-20171157.html"
type: article
quality: 4
heat: 4
published: false

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "OAl0Kx8uX309F1R2CTSDPBskSthldj4UKzAp5dSBh7Osga7pa1dqCLoCd/3FeK6CzdraDFr8cTyClxFuHzSUgXC97ipisJmT3PKsSaGzNgRHJ6ocWAK1/4qrO5rqkv+EKik/gkGjomhfjTFsAkyD69/lxhztK0bO/eXAG0mLWLcCxZ9ABEHE3/PBQeYW2S+i5DYMgpocM6kelvJ2c3aECgeCm8rkxTnOdTtTimmgKvL7A0UJharTtSLtMX5wa3Yi/oYGpg6JevSPJFPkob2YsDVreNwrB/leSNof6pMeAnXNyBm3OaQzHWxTc5b/JaO9hBUF4k4A2T75ivK6IeGX+7Uo1wavm9ITxtTuME9w2H4=;fk0XYeSkPZQKqhz6PGTodQ=="
---

